TABLE 1

Baseline clinical parameters and baseline renal function of type 2 diabetic patients and healthy control subjects

Healthy control subjectsType 2 diabetic patients
n1019
BMI (kg/m2)27.9 ± 1.129.8 ± 1.3
Body surface area (m2)2.00 ± 0.051.98 ± 0.05
Systolic blood pressure (mmHg)135.1 ± 3.6135.3 ± 3.9
Diastolic blood pressure (mmHg)81.8 ± 3.384.0 ± 3.1
MAP (mmHg)96.3 ± 3.399.4 ± 3.4
A1C (%)5.3 ± 0.36.7 ± 0.7*
Fasting plasma glucose (mmol/l)4.9 ± 0.47.4 ± 0.7*
Insulin sensitivity index (Mc) (mg · kg−1 · min−1)6.5 ± 2.92.2 ± 1.1*
LDL cholesterol (mmol/l)3.6 ± 0.33.0 ± 0.7
HDL cholesterol (mmol/l)1.5 ± 0.31.3 ± 0.3
Triglycerides (mmol/l)1.6 ± 0.81.8 ± 0.9
GFR (ml/min)111.7 ± 8.6126.4 ± 7.8
RPF (ml/min)552.3 ± 45.3564.5 ± 21.3
Filtration fraction (%)20.4 ± 1.522.4 ± 1.4
Creatinine (μmol/l)84.1 ± 3.383.8 ± 4.8
Urea (mmol/l)6.0 ± 0.35.4 ± 1.5
  • Data are means ± SE.

  • *

    * P < 0.01.